957 related articles for article (PubMed ID: 18252809)
1. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
2. Directly Observable Behavioral Effects of Lorcaserin in Rats.
Serafine KM; Rice KC; France CP
J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
[TBL] [Abstract][Full Text] [Related]
4. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
5. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
[TBL] [Abstract][Full Text] [Related]
6. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
[TBL] [Abstract][Full Text] [Related]
7. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
Rosenzweig-Lipson S; Zhang J; Mazandarani H; Harrison BL; Sabb A; Sabalski J; Stack G; Welmaker G; Barrett JE; Dunlop J
Brain Res; 2006 Feb; 1073-1074():240-51. PubMed ID: 16430874
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.
Kimura Y; Hatanaka K; Naitou Y; Maeno K; Shimada I; Koakutsu A; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2004 Jan; 483(1):37-43. PubMed ID: 14709324
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
10. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
[TBL] [Abstract][Full Text] [Related]
11. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
Calcagno E; Carli M; Baviera M; Invernizzi RW
J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
[TBL] [Abstract][Full Text] [Related]
12. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
Hemrick-Luecke SK; Evans DC
Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612
[TBL] [Abstract][Full Text] [Related]
14. The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.
Higgins GA; Silenieks LB; Rossmann A; Rizos Z; Noble K; Soko AD; Fletcher PJ
Neuropsychopharmacology; 2012 Apr; 37(5):1177-91. PubMed ID: 22189292
[TBL] [Abstract][Full Text] [Related]
15. Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.
Zayara AE; McIver G; Valdivia PN; Lominac KD; McCreary AC; Szumlinski KK
Psychopharmacology (Berl); 2011 Feb; 213(2-3):321-35. PubMed ID: 20814782
[TBL] [Abstract][Full Text] [Related]
16. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
17. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
Fletcher PJ; Grottick AJ; Higgins GA
Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
[TBL] [Abstract][Full Text] [Related]
19. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
Millan MJ; Dekeyne A; Gobert A
Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
